reboxetine mesilate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack AUST R: 79745Active ingredients:
reboxetine mesilate
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
24 Aug 2026
to
01 Oct 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Commercial Changes / Commercial viability
Management action:
The sponsor is working to expedite the next shipment.
|